Your browser doesn't support javascript.
loading
Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp': reply from the authors.
Stockfleth, E; Harwood, C A; Serra-Guillén, C; Larsson, T; Østerdal, M L; Skov, T.
Afiliação
  • Stockfleth E; Klinik für Dermatologie, Venerologie und Allergologie, St. Josef-Hospital, Bochum, Germany.
  • Harwood CA; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Serra-Guillén C; Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Larsson T; LEO Pharma A/S, Ballerup, Denmark.
  • Østerdal ML; LEO Pharma A/S, Ballerup, Denmark.
  • Skov T; LEO Pharma A/S, Ballerup, Denmark.
Br J Dermatol ; 178(3): 813-814, 2018 03.
Article em En | MEDLINE | ID: mdl-29206275
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ceratose Actínica Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ceratose Actínica Idioma: En Ano de publicação: 2018 Tipo de documento: Article